Last reviewed · How we verify
NCT07190378
Predictive Factors and Monitoring Strategies in Steroid-Induced Diabetes
trial in Steroid-Induced Diabetes in 250 participants. Enrolling by invitation.
5 June 2028
Quick facts
| Lead sponsor | Medical University of Warsaw |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 20 June 2025 |
| Primary completion | 5 June 2028 |
| Estimated completion | 19 June 2028 |
| Sites | 1 location across Poland |
Conditions studied
- Steroid-Induced Diabetes — all drugs for Steroid-Induced Diabetes →
- Diabete Type 2 — all drugs for Diabete Type 2 →
- Steroid Induced Hyperglycemia — all drugs for Steroid Induced Hyperglycemia →
Sponsor
Medical University of Warsaw
Who can join
18 and older, any sex, with Steroid-Induced Diabetes or Diabete Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Glucocorticoids are widely used in the management of autoimmune, inflammatory and neoplastic conditions. However, they are associated with significant metabolic effects, including steroid-induced diabetes (SID). SID is typically diagnosed using general criteria for type 2 diabetes, which may be inadequate due to the unique glycemic profile often seen in SID, where postprandial hyperglycemia predominates. This research aims to explore the diagnostic value of CGM during steroid therapy and identify risk factors for SID This is a prospective observational study (n=250) enrolling adults initiating glucocorticoid therapy. Participants will undergo 14-day continuous glucose monitoring (CGM) to assess predictive factors and glycemic profile.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07190378
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Steroid-Induced Diabetes
Currently open trials in the same condition.
- NCT06318442 — The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes · NA · recruiting
Other Medical University of Warsaw trials
Trials by the same sponsor.
- NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
- NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
- NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
- NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
- NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07190378 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07190378.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing